S'abonner

Prevalence and features of IOS-defined small airway disease across asthma severities - 12/02/21

Doi : 10.1016/j.rmed.2020.106243 
Marcello Cottini a, , Anita Licini a, Carlo Lombardi b, Alvise Berti c,
a Allergy and Pneumology Outpatient Clinic, Bergamo, Italy 
b Departmental Unit of Allergology, Immunology & Pulmonary Diseases, Fondazione Poliambulanza, Brescia, Italy 
c Santa Chiara Hospital and Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento, Italy and Thoracic Disease Research Unit, Mayo Clinic, Rochester, USA 

Corresponding author. Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari - Provincia Autonoma di Trento, Largo Medaglie D'Oro 9, Trento, Italy.Santa Chiara HospitalAzienda Provinciale per i Servizi Sanitari - Provincia Autonoma di TrentoLargo Medaglie D'Oro 9TrentoItaly∗∗Corresponding author. Allergy and Pneumology Outpatient Clinic, Via Borgo Palazzo 116, Bergamo, 24125, Italy.Allergy and Pneumology Outpatient ClinicVia Borgo Palazzo 116Bergamo24125Italy

Abstract

Background

Impulse oscillometry (IOS) is a noninvasive method based on the forced oscillation technique able to detect small airway dysfunction (SAD) in asthma. We aimed to analyze the prevalence and the functional features of IOS-defined SAD across the different Global Initiative for Asthma (GINA) steps.

Methods

A cross-sectional, single-center study in which 400 consecutive adult patients with physician-diagnosed, community-managed asthma underwent standard spirometry and IOS, and were stratified by stepwise GINA classification. SAD was defined by IOS as a fall in resistance from 5 to 20 Hz [R5–R20]>0.07kPa × s × L−1.

Results

The prevalence of IOS-defined SAD ranged between 58.3% (GINA step 2) and 78.6% (GINA step 5), without statistically significant difference within GINA steps (p > 0.05 in all comparisons). Isolated SAD (i.e. without proximal airways involvement) was similarly represented across GINA steps 2–4. Peripheral airways resistance (R5-R20) tended to a progressive increase with the worsening of GINA steps, and was significantly higher in steps 4–5 compared to the other steps (p < 0.05).

The proportion of patients with FEF25–75%-defined SAD (<60%) was lower than the IOS-defined one in GINA steps 2–4 (p < 0.05). Only non-significant or weak inverse correlations between R5-R20 and FEF25–75% were observed within each GINA step, with the exception of GINA step 5, which showed a strong, inverse correlation (r = −0.80, p = 0.0005).

Conclusions

This study shows that first, IOS-defined SAD is overwhelmingly present across asthma severities; second, airways resistance increases with the worsening of GINA steps; and third, SAD may be overlooked by standard spirometry, especially in milder asthma.

Le texte complet de cet article est disponible en PDF.

Highlights

In community-managed asthma, the prevalence of IOS-defined SAD and isolated SAD (i.e. without proximal airways involvement) is significantly represented across GINA steps, suggesting that SAD is overwhelmingly present in asthma.
By means of IOS, peripheral airways resistance (R5-R20) increases with the worsening of GINA steps, and particularly in steps 4–5, suggesting SAD implication in the determination of asthma severity.
Conventional spirometry does not reveal the presence of SAD in GINA steps 2-4, as shown by the nonsignificant or weak inverse correlations between R5-R20 and FEF at 25–75%.
A significantly lower proportion of SAD is detected in GINA steps 2–4 by FEF at 25–75%, compared to IOS.
Overall, this suggests that SAD may be adequately assessed by standard spirometry only in most severe cases, and potentially overlooked in all the others.

Le texte complet de cet article est disponible en PDF.

Keywords : Asthma, Community-treated asthma, Small airways, Small airways dysfunction, Oscillometry, IOS

Abbreviations : SAD, IOS, FeNO, BMI, FEV1, FVC, FEF25-75, R5-R20, X5, Ax, FRes, ICS, LABA, LAMA


Plan


© 2020  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 176

Article 106243- janvier 2021 Retour au numéro
Article précédent Article précédent
  • Outpatient management of primary spontaneous pneumothorax
  • Stéphane Jouneau, Constance Vuillard, Alexandre Salé, Yann Bazin, Laurent Sohier, Mallorie Kerjouan, Jean-Damien Ricard, Jonathan Messika
| Article suivant Article suivant
  • Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity
  • Marco Caminati, Alessandra Vultaggio, Andrea Matucci, Gianenrico Senna, Francesco Almerigogna, Diego Bagnasco, Fulvia Chieco-Bianchi, Filippo Cosini, Domenico Girelli, Gabriella Guarnieri, Francesco Menzella, Claudio Micheletto, Oliviero Olivieri, Gianni Passalacqua, Laura Pini, Oliviero Rossi, Andrea Vianello, Emanuele Vivarelli, Ernesto Crisafulli

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.